SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,761,600 | -63.4% | 80,000 | -67.3% | 0.47% | -77.5% |
| Q1 2023 | $10,280,200 | -25.1% | 245,000 | -31.9% | 2.07% | -28.1% |
| Q4 2022 | $13,730,400 | -1.8% | 360,000 | +0.8% | 2.88% | +6.1% |
| Q3 2022 | $13,980,000 | +5.0% | 357,000 | -13.4% | 2.72% | -0.8% |
| Q2 2022 | $13,316,000 | +29.4% | 412,257 | +32.6% | 2.74% | +2.2% |
| Q1 2022 | $10,294,000 | -40.8% | 311,000 | -24.0% | 2.68% | -44.4% |
| Q4 2021 | $17,399,000 | +23.1% | 409,000 | +28.2% | 4.82% | +18.5% |
| Q3 2021 | $14,135,000 | +11.1% | 319,000 | +42.4% | 4.06% | +16.0% |
| Q2 2021 | $12,725,000 | +18.1% | 224,000 | +55.6% | 3.50% | +13.7% |
| Q1 2021 | $10,778,000 | -36.1% | 144,000 | -26.2% | 3.08% | -38.6% |
| Q4 2020 | $16,869,000 | +20.0% | 195,000 | -15.2% | 5.02% | +16.7% |
| Q3 2020 | $14,058,000 | +73.4% | 230,000 | +17.9% | 4.30% | +77.1% |
| Q2 2020 | $8,108,000 | +66.1% | 195,000 | +14.7% | 2.43% | +12.9% |
| Q1 2020 | $4,882,000 | -43.6% | 170,000 | +41.7% | 2.15% | -36.3% |
| Q4 2019 | $8,663,000 | – | 120,000 | – | 3.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |